FDA Inspection
Spectrum Laboratory Products, Inc.Spectrum Laboratory Products, Inc. – FDA Inspection, Mar 24, 2023
Record Details
This FDA Inspection record concerns Spectrum Laboratory Products, Inc., with an inspection on March 24, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Barbara J. Wilimczyk-Macri
- Elaine E. Gilfillan
- Sayyem H. Akbar (FDA Associated Person)
View Company Profile
ID · abbfe9f6-4814-4c92-be6a-65eacc98f0fe
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1200726
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Spectrum Laboratory Products, Inc.
8| Date | Classification | Office | Project area |
|---|---|---|---|
| February 19, 2025 | Not classified | New Jersey District Office | |
| July 14, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 12, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 14, 2016 | VAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| August 16, 2013 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for Spectrum Laboratory Products, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.